ITGR(Integer Holdings Corporation) · 财务报表

ITGR(Integer Holdings Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$1.22B$1.33B$1.56B$1.72B$1.85B
毛利润$336.97M$345.76M$409.89M$459.01M$500.39M
营业利润$135.71M$112.68M$163.32M$208.24M$221.26M
净利润$96.81M$66.38M$90.65M$119.90M$102.81M
经营现金流$156.67M$116.38M$180.21M$205.21M$196.15M
自由现金流$103.20M$41.65M$60.27M$99.85M$105.12M
摊薄每股收益$2.91$1.99$2.69$3.36$2.89

Integer Holdings Corporation ITGR